The European mesothelioma epidemic

Abstract

Projections for the period 1995-2029 suggest that the number of men dying from mesothelioma in Western Europe each year will almost double over the next 20 years, from 5000 in 1998 to about 9000 around 2018, and then decline, with a total of about a quarter of a million deaths over the next 35 years. The highest risk will be suffered by men born around 1945-50, of whom about 1 in 150 will die of mesothelioma. Asbestos use in Western Europe remained high until 1980, and substantial quantities are still used in several European countries. These projections are based on the fit of a simple age and birth cohort model to male pleural cancer mortality from 1970 to 1989 for six countries (Britain, France, Germany, Italy, The Netherlands and Switzerland) which together account for three-quarters of the population of Western Europe. The model was tested by comparing observed and predicted numbers of deaths for the period 1990-94. The ratio of mesothelioma to recorded pleural cancer mortality has been 1.6:1 in Britain but was assumed to be 1:1 in other countries.

References 8

1. 1.

   Cullen M. R. Chrysotile asbestos: enough is enough. Lancet. 1998;351(9113):1377-1378.

   Not in our library10.1016/s0140-6736(05)79440-x

2. 2.

   Decarli A., La Vecchia C., Mezzanotte G., Cislaghi C. Birth cohort, time, and age effects in Italian cancer mortality. Cancer. 1987;59(6):1221-1232.

   Not in our library10.1002/1097-0142(19870315)59:6<1221::aid-cncr2820590632>3.0.co;2-3

3. 3.

   Dement J. M., Harris R. L., Symons M. J., Shy C. M. Exposures and mortality among chrysotile asbestos workers. Part I: exposure estimates. Am J Ind Med. 1983;4(3):399-419.

   Not in our library10.1002/ajim.4700040303

4. 4.

   Dement J. M., Harris R. L., Symons M. J., Shy C. M. Exposures and mortality among chrysotile asbestos workers. Part II: mortality. Am J Ind Med. 1983;4(3):421-433.

   Not in our library10.1002/ajim.4700040304

5. 5.

   La Vecchia C., Lucchini F., Negri E., Boyle P., Maisonneuve P., Levi F. Trends of cancer mortality in Europe, 1955-1989: II, Respiratory tract, bone, connective and soft tissue sarcomas, and skin. Eur J Cancer. 1992;28(2-3):514-599.

   Not in our library10.1016/s0959-8049(05)80091-7

6. 6.

   McDonald A. D., Case B. W., Churg A., Dufresne A., Gibbs G. W., Sébastien P., McDonald J. C. Mesothelioma in Quebec chrysotile miners and millers: epidemiology and aetiology. Ann Occup Hyg. 1997;41(6):707-719.

   Not in our library10.1016/s0003-4878(97)00020-3

7. 7.

   McDonald A. D., Fry J. S., Woolley A. J., McDonald J. Dust exposure and mortality in an American chrysotile textile plant. Br J Ind Med. 1983;40(4):361-367.

   Not in our library10.1136/oem.40.4.361

8. 8.
   Mesothelioma mortality in asbestos workers: Implications for models of carcinogenesis and risk assessment · 1982

   No notice

Cited by papers we hold 8

• Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma · 2020
  Not checked
• Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma · 2018
  Not checked
• Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models. · 2017
  Not checked
• Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. · 2013
  Not checked
• Global Magnitude of Reported and Unreported Mesothelioma · 2011
  No notice
• Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study · 2011
  No notice
• Terapêutica do mesotelioma · 2008
  Not checked
• The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050 · 2005
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.